ArticleThe Lancet regional health. Europe2023

Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study.

Rolof G P Gijtenbeek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.